43
Participants
Start Date
October 31, 2012
Primary Completion Date
May 31, 2016
Study Completion Date
May 31, 2016
AZD0424
"AZD0424 will be administered as a flat dose orally once a day. One treatment cycle consists of 28 days of continuous drug administration with AZD0424, with the flexibility to introduce treatment breaks if required due to cumulative toxicity.~Combination agents and treatment regimen with AZD0424 will be confirmed and approved at a later date."
Belfast City Hospital, Belfast
Edinburgh Cancer Centre - Western General Hospital, Edinburgh
Oxford University Hospitals NHS Trust, Oxford
Lead Sponsor
Cancer Research UK
OTHER